Perioperative Levels of Troponin and BNP and the Outcome after Coronary Artery Bypass Grafting
DOI:
https://doi.org/10.1532/hsf.5471Keywords:
atrial natriuretic peptide, cardiac troponin I, coronary artery bypass grafting, prognosisAbstract
Background: The independent predictive values of troponin I (cTnI) and B-type natriuretic peptide (BNP) after coronary artery bypass grafting (CABG) have been reported in several studies. However, adjustment only has been limited to preoperative risk factors. Aim: This study was conducted to assess the independent values of postoperative cTnI and BNP to predict the outcome after CABG with adjustment for preoperative risk estimates and postoperative complications and to report risk stratification gains, when considering the European System for Cardiac Operative Risk Evaluation (EuroSCORE) combined with postoperative biomarkers. Methods: This retrospective cohort study included 282 consecutive patients undergoing CABG between January 2018 and December 2021. We evaluated the preoperative and postoperative cTnI and BNP, EuroSCORE, and postoperative complications. The composite endpoint was death or cardiac-related adverse events. Results: The AUROC for postoperative cTnI was significantly higher than that of BNP (0.777 vs. 0.625, p = 0.041). The optimal cut-off values to predict the composite outcome were >4830 (pg/mL) and >6.95 (ng/mL) for BNP and cTnI, respectively. Adjustment for relevant and significant perioperative factors showed that postoperative BNP and cTnI had a high discriminatory power (C-index = 0.773 and 0.895, respectively) for predicting major adverse events. Conclusions: Postoperative BNP and cTnI are independent predictors of death or major adverse events, following CABG, and can add to the predictive power of EuroSCORE II.
References
Bachar BJ, Manna B. Coronary Artery Bypass Graft. StatPearls Publishing: Treasure Island (FL). 2023.
Reiche S, Mpanya D, Vanderdonck K, Mogaladi S, Motshabi-Chakane P, Tsabedze N. Perioperative outcomes of coronary artery bypass graft surgery in Johannesburg, South Africa. Journal of Cardiothoracic Surgery. 2021; 16: 7.
Saraiya NR, Sun LS, Jonassen AE, Pesce MA, Queagebeur JM. Serum cardiac troponin-I elevation in neonatal cardiac surgery is lesion-dependent. Journal of Cardiothoracic and Vascular Anesthesia. 2005; 19: 620–625.
Fox AA, Marcantonio ER, Collard CD, Thoma M, Perry TE, Shernan SK, et al. Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery. Anesthesiology. 2011; 114: 807–816.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio-Thoracic Surgery. 1999; 16: 9–13.
Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. European Journal of Cardio-Thoracic Surgery. 2012; 41: 734–745.
Omran F, Kyrou I, Osman F, Lim VG, Randeva HS, Chatha K. Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future. International Journal of Molecular Sciences. 2022; 23: 5680.
Stark M, Kerndt CC, Sharma S. Troponin. StatPearls Publishing: Treasure Island (FL). 2022.
Wolfe Barry JA, Barth JH, Howell SJ. Cardiac troponins: their use and relevance in anaesthesia and critical care medicine. Continuing Education in Anaesthesia Critical Care & Pain. 2008; 8: 62–66.
Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, et al. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology. 2010; 112: 842–851.
Fellahi JL, Hanouz JL, Le Manach Y, Gué X, Monier E, Guillou L, et al. Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery. Anesthesiology. 2009; 111: 250–257.
Ma QL, Wang HJ, Shi MN, An JH, Ma J, Yu D, et al. Serum troponin I concentrations assessed 18-24 hours after coronary artery bypass grafting are significant predictors of early patient prognosis. European Review for Medical and Pharmacological Sciences. 2016; 20: 4129–4135.
Devereaux PJ, Lamy A, Chan MTV, Allard RV, Lomivorotov VV, Landoni G, et al. High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. The New England Journal of Medicine. 2022; 386: 827–836.
Søraas CL, Friis C, Engebretsen KVT, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. American Heart Journal. 2012; 164: 779–785.
Lurati Buse GAL, Bolliger D, Seeberger E, Kasper J, Grapow M, Koller MT, et al. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. Circulation. 2014; 130: 948–957.
Kubota H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, et al. Deep sternal wound infection after cardiac surgery. Journal of Cardiothoracic Surgery. 2013; 8: 132.
Tolpin DA, Collard CD, Lee VV, Virani SS, Allison PM, Elayda MA, et al. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2012; 143: 682–688.e1.
Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS, et al. Troponin after cardiac surgery: a predictor or a phenomenon? The Annals of Thoracic Surgery. 2008; 85: 1348–1354.
Mauermann E, Bolliger D, Fassl J, Grapow M, Seeberger EE, Seeberger MD, et al. Absolute Postoperative B-Type Natriuretic Peptide Concentrations, but Not Their General Trend, Are Associated With 12-Month, All-Cause Mortality After On-Pump Cardiac Surgery. Anesthesia and Analgesia. 2017; 125: 753–761.
Lurati Buse GA, Koller MT, Grapow M, Brüni CM, Kasper J, Seeberger MD, et al. 12-month outcome after cardiac surgery: prediction by troponin T in combination with the European system for cardiac operative risk evaluation. The Annals of Thoracic Surgery. 2009; 88: 1806–1812.
Fox AA, Nascimben L, Body SC, Collard CD, Mitani AA, Liu KY, et al. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery. Anesthesiology. 2013; 119: 284–294.
Adabag AS, Rector T, Mithani S, Harmala J, Ward HB, Kelly RF, et al. Prognostic significance of elevated cardiac troponin I after heart surgery. The Annals of Thoracic Surgery. 2007; 83: 1744–1750.
Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation. 2006; 114: 1468–1475.
Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. The prognostic value of troponin release after adult cardiac surgery - a meta-analysis. European Journal of Cardio-Thoracic Surgery. 2010; 37: 399–406
Petäjä L, Røsjø H, Mildh L, Suojaranta-Ylinen R, Kaukonen KM, Jokinen JJ, et al. Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interactive Cardiovascular and Thoracic Surgery. 2016; 23: 133–141.
Mauermann E, Bolliger D, Fassl J, Grapow M, Seeberger EE, Seeberger MD, et al. Postoperative High-Sensitivity Troponin and Its Association With 30-Day and 12-Month, All-Cause Mortality in Patients Undergoing On-Pump Cardiac Surgery. Anesthesia and Analgesia. 2017; 125: 1110–1117.